REPORT ID 686

EMEA (Europe, Middle East and Africa) Extracorporeal Membrane Oxygenation (ECMO) Systems Market Report 2017

Publish Date
01-Dec-17
Pages
108
Format
Electronic (PDF)

In this report, the EMEA Extracorporeal Membrane Oxygenation (ECMO) Systems market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Extracorporeal Membrane Oxygenation (ECMO) Systems for these regions, from 2012 to 2022 (forecast)
    Europe: Germany, France, UK, Russia, Italy and Benelux;
    Middle East: Saudi Arabia, Israel, UAE and Iran;
    Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Extracorporeal Membrane Oxygenation (ECMO) Systems market competition by top manufacturers/players, with Extracorporeal Membrane Oxygenation (ECMO) Systems sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including
    Maquet Holding
    Medtronic
    Microport Scientific
    Terumo Cardiovascular Systems
    Medos Medizintechnik
    Nipro Medical
    Sorin Group
    ...

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Veno-Arterial
    Veno-Venous

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
    Neonates
    Pediatric
    Adult

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

EMEA (Europe, Middle East and Africa) Extracorporeal Membrane Oxygenation (ECMO) Systems Market Report 2017
1 Extracorporeal Membrane Oxygenation (ECMO) Systems Overview
    1.1 Product Overview and Scope of Extracorporeal Membrane Oxygenation (ECMO) Systems
    1.2 Classification of Extracorporeal Membrane Oxygenation (ECMO) Systems
        1.2.1 EMEA Extracorporeal Membrane Oxygenation (ECMO) Systems Market Size (Sales) Comparison by Type (2012-2022)
        1.2.2 EMEA Extracorporeal Membrane Oxygenation (ECMO) Systems Market Size (Sales) Market Share by Type (Product Category) in 2016
        1.2.3 Veno-Arterial
        1.2.4 Veno-Venous
    1.3 EMEA Extracorporeal Membrane Oxygenation (ECMO) Systems Market by Application/End Users
        1.3.1 EMEA Extracorporeal Membrane Oxygenation (ECMO) Systems Sales (Volume) and Market Share Comparison by Application (2012-2022
        1.3.2 Neonates
        1.3.3 Pediatric
        1.3.4 Adult
    1.4 EMEA Extracorporeal Membrane Oxygenation (ECMO) Systems Market by Region
        1.4.1 EMEA Extracorporeal Membrane Oxygenation (ECMO) Systems Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 Europe Status and Prospect (2012-2022)
        1.4.3 Middle East Status and Prospect (2012-2022)
        1.4.4 Africa Status and Prospect (2012-2022)
    1.5 EMEA Market Size (Value and Volume) of Extracorporeal Membrane Oxygenation (ECMO) Systems (2012-2022)
        1.5.1 EMEA Extracorporeal Membrane Oxygenation (ECMO) Systems Sales and Growth Rate (2012-2022)
        1.5.2 EMEA Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue and Growth Rate (2012-2022)

2 EMEA Extracorporeal Membrane Oxygenation (ECMO) Systems Competition by Manufacturers/Players/Suppliers, Region, Type and Application
    2.1 EMEA Extracorporeal Membrane Oxygenation (ECMO) Systems Market Competition by Players/Manufacturers
        2.1.1 EMEA Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Volume and Market Share of Major Players (2012-2017)
        2.1.2 EMEA Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue and Share by Players (2012-2017)
        2.1.3 EMEA Extracorporeal Membrane Oxygenation (ECMO) Systems Sale Price by Players (2012-2017)
    2.2 EMEA Extracorporeal Membrane Oxygenation (ECMO) Systems (Volume and Value) by Type/Product Category
        2.2.1 EMEA Extracorporeal Membrane Oxygenation (ECMO) Systems Sales and Market Share by Type (2012-2017)
        2.2.2 EMEA Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue and Market Share by Type (2012-2017)
        2.2.3 EMEA Extracorporeal Membrane Oxygenation (ECMO) Systems Sale Price by Type (2012-2017)
    2.3 EMEA Extracorporeal Membrane Oxygenation (ECMO) Systems (Volume) by Application
    2.4 EMEA Extracorporeal Membrane Oxygenation (ECMO) Systems (Volume and Value) by Region
        2.4.1 EMEA Extracorporeal Membrane Oxygenation (ECMO) Systems Sales and Market Share by Region (2012-2017)
        2.4.2 EMEA Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue and Market Share by Region (2012-2017)
        2.4.3 EMEA Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Price by Region (2012-2017)

3 Europe Extracorporeal Membrane Oxygenation (ECMO) Systems (Volume, Value and Sales Price), by Players, Countries, Type and Application
    3.1 Europe Extracorporeal Membrane Oxygenation (ECMO) Systems Sales and Value (2012-2017)
        3.1.1 Europe Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Volume and Growth Rate (2012-2017)
        3.1.2 Europe Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue and Growth Rate (2012-2017)
    3.2 Europe Extracorporeal Membrane Oxygenation (ECMO) Systems Sales and Market Share by Type
    3.3 Europe Extracorporeal Membrane Oxygenation (ECMO) Systems Sales and Market Share by Application
    3.4 Europe Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Volume and Value (Revenue) by Countries
        3.4.1 Europe Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Volume by Countries (2012-2017)
        3.4.2 Europe Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Countries (2012-2017)
        3.4.3 Germany Extracorporeal Membrane Oxygenation (ECMO) Systems Sales and Growth Rate (2012-2017)
        3.4.4 France Extracorporeal Membrane Oxygenation (ECMO) Systems Sales and Growth Rate (2012-2017)
        3.4.5 UK Extracorporeal Membrane Oxygenation (ECMO) Systems Sales and Growth Rate (2012-2017)
        3.4.6 Russia Extracorporeal Membrane Oxygenation (ECMO) Systems Sales and Growth Rate (2012-2017)
        3.4.7 Italy Extracorporeal Membrane Oxygenation (ECMO) Systems Sales and Growth Rate (2012-2017)
        3.4.8 Benelux Extracorporeal Membrane Oxygenation (ECMO) Systems Sales and Growth Rate (2012-2017)

4 Middle East Extracorporeal Membrane Oxygenation (ECMO) Systems (Volume, Value and Sales Price), by Region, Type and Application
    4.1 Middle East Extracorporeal Membrane Oxygenation (ECMO) Systems Sales and Value (2012-2017)
        4.1.1 Middle East Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Volume and Growth Rate (2012-2017)
        4.1.2 Middle East Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue and Growth Rate (2012-2017)
    4.2 Middle East Extracorporeal Membrane Oxygenation (ECMO) Systems Sales and Market Share by Type
    4.3 Middle East Extracorporeal Membrane Oxygenation (ECMO) Systems Sales and Market Share by Application
    4.4 Middle East Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Volume and Value (Revenue) by Countries
        4.4.1 Middle East Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Volume by Countries (2012-2017)
        4.4.2 Middle East Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Countries (2012-2017)
        4.4.3 Saudi Arabia Extracorporeal Membrane Oxygenation (ECMO) Systems Sales and Growth Rate (2012-2017)
        4.4.4 Israel Extracorporeal Membrane Oxygenation (ECMO) Systems Sales and Growth Rate (2012-2017)
        4.4.5 UAE Extracorporeal Membrane Oxygenation (ECMO) Systems Sales and Growth Rate (2012-2017)
        4.4.6 Iran Extracorporeal Membrane Oxygenation (ECMO) Systems Sales and Growth Rate (2012-2017)

5 Africa Extracorporeal Membrane Oxygenation (ECMO) Systems (Volume, Value and Sales Price) by Players, Countries, Type and Application
    5.1 Africa Extracorporeal Membrane Oxygenation (ECMO) Systems Sales and Value (2012-2017)
        5.1.1 Africa Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Volume and Growth Rate (2012-2017)
        5.1.2 Africa Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue and Growth Rate (2012-2017)
    5.2 Africa Extracorporeal Membrane Oxygenation (ECMO) Systems Sales and Market Share by Type
    5.3 Africa Extracorporeal Membrane Oxygenation (ECMO) Systems Sales and Market Share by Application
    5.4 Africa Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Volume and Value (Revenue) by Countries
        5.4.1 Africa Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Volume by Countries (2012-2017)
        5.4.2 Africa Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue by Countries (2012-2017)
        5.4.3 South Africa Extracorporeal Membrane Oxygenation (ECMO) Systems Sales and Growth Rate (2012-2017)
        5.4.4 Nigeria Extracorporeal Membrane Oxygenation (ECMO) Systems Sales and Growth Rate (2012-2017)
        5.4.5 Egypt Extracorporeal Membrane Oxygenation (ECMO) Systems Sales and Growth Rate (2012-2017)
        5.4.6 Algeria Extracorporeal Membrane Oxygenation (ECMO) Systems Sales and Growth Rate (2012-2017)

6 EMEA Extracorporeal Membrane Oxygenation (ECMO) Systems Manufacturers/Players Profiles and Sales Data
    6.1 Maquet Holding
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Extracorporeal Membrane Oxygenation (ECMO) Systems Product Type, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Maquet Holding Extracorporeal Membrane Oxygenation (ECMO) Systems Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Medtronic
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Extracorporeal Membrane Oxygenation (ECMO) Systems Product Type, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Medtronic Extracorporeal Membrane Oxygenation (ECMO) Systems Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Microport Scientific
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Extracorporeal Membrane Oxygenation (ECMO) Systems Product Type, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Microport Scientific Extracorporeal Membrane Oxygenation (ECMO) Systems Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Terumo Cardiovascular Systems
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Extracorporeal Membrane Oxygenation (ECMO) Systems Product Type, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Terumo Cardiovascular Systems Extracorporeal Membrane Oxygenation (ECMO) Systems Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Medos Medizintechnik
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Extracorporeal Membrane Oxygenation (ECMO) Systems Product Type, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Medos Medizintechnik Extracorporeal Membrane Oxygenation (ECMO) Systems Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Nipro Medical
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Extracorporeal Membrane Oxygenation (ECMO) Systems Product Type, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Nipro Medical Extracorporeal Membrane Oxygenation (ECMO) Systems Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Sorin Group
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Extracorporeal Membrane Oxygenation (ECMO) Systems Product Type, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Sorin Group Extracorporeal Membrane Oxygenation (ECMO) Systems Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    ...

7 Extracorporeal Membrane Oxygenation (ECMO) Systems Manufacturing Cost Analysis
    7.1 Extracorporeal Membrane Oxygenation (ECMO) Systems Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Extracorporeal Membrane Oxygenation (ECMO) Systems

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Extracorporeal Membrane Oxygenation (ECMO) Systems Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Extracorporeal Membrane Oxygenation (ECMO) Systems Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 EMEA Extracorporeal Membrane Oxygenation (ECMO) Systems Market Forecast (2017-2022)
    11.1 EMEA Extracorporeal Membrane Oxygenation (ECMO) Systems Sales, Revenue and Price Forecast (2017-2022)
        11.1.1 EMEA Extracorporeal Membrane Oxygenation (ECMO) Systems Sales and Growth Rate Forecast (2017-2022)
        11.1.2 EMEA Extracorporeal Membrane Oxygenation (ECMO) Systems Revenue and Growth Rate Forecast (2017-2022)
        11.1.3 EMEA Extracorporeal Membrane Oxygenation (ECMO) Systems Price and Trend Forecast (2017-2022)
    11.2 EMEA Extracorporeal Membrane Oxygenation (ECMO) Systems Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.3 Europe Extracorporeal Membrane Oxygenation (ECMO) Systems Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.4 Middle Eastt Extracorporeal Membrane Oxygenation (ECMO) Systems Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.5 Africa Extracorporeal Membrane Oxygenation (ECMO) Systems Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
    11.6 EMEA Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Forecast by Type (2017-2022)
    11.7 EMEA Extracorporeal Membrane Oxygenation (ECMO) Systems Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer